Buyer for regulatory consultancy company in Europe

Company to buy

• Size: Small to mid-sized business
• Revenue: 2 – 20 million EUR
• Target location: Europe
• CFIE PHB260

Overview of buyer for regulatory consultancy company in Europe

Established in 2007, this company has emerged as a pioneer in regulatory consultancy. Primarily, it specializes in guiding medical and diagnostic product manufacturers through complex regulatory landscapes. Initially, it was focused on importing medical products. Later, the company expanded its services by investing in domestic production facilities. Then, the company further strengthened its position by establishing state-of-the-art R&D and production laboratories specializing in molecular genetics. Altogether, these advancements have enabled the company to offer comprehensive regulatory consultancy alongside its diverse product portfolio.

Profile of buyer for regulatory consultancy company in Europe

Renowned for its expertise in regulatory affairs, this company collaborates with prestigious institutions. For example, the University of Environmental and Life Sciences and the Institute of Immunology and Experimental Therapy. Notably, the company’s commitment to excellence is demonstrated through its ISO 13485:2016 certification and adherence to CE directives. By providing expert guidance on global regulatory requirements, the company supports clients in achieving compliance and market access. As a result, it fosters innovation and ensures the highest quality standards in the medical and diagnostic fields.

Activity and products of buyer for regulatory consultancy company in Europe

The company’s core activities include offering comprehensive regulatory consultancy services and producing a wide range of molecular biology products. Further, their consultancy services encompass regulatory support for certifications such as CE, FDA, UKCA, Med Do, CDSCO, and NMPA. The product lineup includes PCR, RT-qPCR Master Mixes, PCR components, magnetic bead nucleic acid extraction kits, pathogen detection kits, agarose gel electrophoresis products, molecular biology grade reagents, and rapid test kits for various diseases. Above all, these offerings are designed to meet the evolving needs of the scientific and healthcare communities

Highlights of buyer for regulatory consultancy company in Europe

• As a pioneer in regulatory consultancy, the company provides invaluable support to medical device and diagnostic product manufacturers, ensuring seamless compliance with global regulations.
• The establishment of advanced R&D and production laboratories has significantly enhanced the company’s capacity to offer high-quality molecular biology products.
• The company’s ISO 13485:2016 certification and CE compliance underscore its dedication to maintaining the highest quality standards.
• With a focus on client satisfaction, the company offers private label, OEM, and OBL product services, demonstrating flexibility and adaptability to meet specific client needs.
• The company’s proactive participation in international fairs and industry exhibitions highlights its commitment to staying at the forefront of regulatory and industry developments.
• By leveraging its extensive network of global contacts, the company provides comprehensive support for market access and regulatory compliance, helping clients navigate complex regulatory environments with ease.

More information on this buyer for regulatory consultancy company in Europe

Please get in touch if you are interested in learning more about this buyer for regulatory consultancy company in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.